Northwire Canada EditionFriday, July 17, 2026
Sign inSubscribe
Northwire
⌕
LUN 33.59 −2.5% NTR 94.27 −1.8% LALI 0.055 −8.3% SCD 0.170 +0.0% HWY 0.370 +0.0% FCI 0.385 +1.3% GGAU 0.180 −5.3% KIRO 0.650 +1.6% LBNK 0.430 +0.0% BARU 0.040 +0.0% VCU 1.09 −4.4% NOBL 0.095 −5.0% SHL 0.355 +0.0% MTS 0.130 +0.0% FYL 0.090 +0.0% NUAG 5.55 +1.8% LUN 33.59 −2.5% NTR 94.27 −1.8% LALI 0.055 −8.3% SCD 0.170 +0.0% HWY 0.370 +0.0% FCI 0.385 +1.3% GGAU 0.180 −5.3% KIRO 0.650 +1.6% LBNK 0.430 +0.0% BARU 0.040 +0.0% VCU 1.09 −4.4% NOBL 0.095 −5.0% SHL 0.355 +0.0% MTS 0.130 +0.0% FYL 0.090 +0.0% NUAG 5.55 +1.8%

Healthcare

Page 91
  1. Dec 04, 2025 · 08:45 · GSD

    Devonian Health Group Announces Publication of Landmark Study Highlighting Thykamine(TM) as a Promising New Anti-Inflammatory Agent

    Devonian Health Group Announces Publication of Landmark Study Highlighting Thykamine(TM) as a Promising New Anti-Inflammatory Agent

    01
  2. Dec 04, 2025 · 08:00 · BETR

    BetterLife Pharma Highlights Advantages of BETR-001 -- a Potent Neuroplastogen

    BetterLife Pharma Highlights Advantages of BETR-001 -- a Potent Neuroplastogen

    02
  3. Dec 04, 2025 · 08:00 · AIDR

    Rocket Doctor Announces First in Canada Strategic Partnership with Toronto Metropolitan University to Support Clinical Education of Medical Learners on a Digital Health Platform

    Rocket Doctor Announces First in Canada Strategic Partnership with Toronto Metropolitan University to Support Clinical Education of Medical Learners on a Digital Health Platform

    03
  4. Dec 04, 2025 · 07:02 · PREV

    PreveCeutical Announces Grant of Patent for Innovative Pain Therapy Technology

    PreveCeutical Announces Grant of Patent for Innovative Pain Therapy Technology

    04
  5. Dec 04, 2025 · 07:00 · COV

    Covalon Announces Conference Call to Discuss Fourth Quarter and Year End Fiscal 2025 Financial Results

    Covalon Announces Conference Call to Discuss Fourth Quarter and Year End Fiscal 2025 Financial Results

    05
  6. Dec 03, 2025 · 18:38 · EXE

    Extendicare closes $200-million private placement

    Extendicare closes $200-million private placement

    06
  7. Dec 03, 2025 · 17:01 · MYTC

    MyndTec Inc. Completes Eighth Tranche of Non-Brokered Private Placement

    MyndTec Inc. Completes Eighth Tranche of Non-Brokered Private Placement

    07
  8. Dec 03, 2025 · 16:30 · MBX

    Microbix to provide QAPs to Seegene for HPV assays

    Microbix to provide QAPs to Seegene for HPV assays

    08
  9. Dec 03, 2025 · 14:05 · HEM

    Hemostemix Featured at Innovations in Wound Healing 2025, Key West, December 11-14

    Hemostemix Featured at Innovations in Wound Healing 2025, Key West, December 11-14

    09
  10. Dec 03, 2025 · 11:23 · VIVI

    Tempramed signs exclusive Turkish distribution deal

    Tempramed signs exclusive Turkish distribution deal

    10
  11. Dec 03, 2025 · 10:30 · KDA

    KDA GROUP ANNOUNCES PARTNERSHIP AGREEMENT WITH CHU DE QUEBEC-UNIVERSITE LAVAL FOR THE DEPLOYMENT OF MEDHERIZE

    KDA GROUP ANNOUNCES PARTNERSHIP AGREEMENT WITH CHU DE QUEBEC-UNIVERSITE LAVAL FOR THE DEPLOYMENT OF MEDHERIZE

    11
  12. Dec 03, 2025 · 08:57 · EXE

    Extendicare Completes Previously Announced $200 Million Private Placement of Common Shares

    Extendicare Completes Previously Announced $200 Million Private Placement of Common Shares

    12
  13. Dec 03, 2025 · 07:00 · MBX

    Microbix & Seegene Mexico Collaborate to Improve Test Accuracy

    Microbix & Seegene Mexico Collaborate to Improve Test Accuracy

    13
  14. Dec 02, 2025 · 20:01 · PHRM

    Pharmather closes sale of ketamine ANDA

    Pharmather closes sale of ketamine ANDA

    14
← Newer Older →